Digirad Corp. (NASDAQ:DRAD) Director Jeffrey E. Eberwein bought 5,625 shares of Digirad Corp. stock in a transaction that occurred on Wednesday, September 14th. The stock was bought at an average price of $5.00 per share, for a total transaction of $28,125.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Digirad Corp. (NASDAQ:DRAD) opened at 4.98 on Wednesday. The stock’s 50 day moving average price is $5.11 and its 200-day moving average price is $5.26. Digirad Corp. has a 12 month low of $3.65 and a 12 month high of $6.92. The firm has a market capitalization of $97.45 million, a price-to-earnings ratio of 3.05 and a beta of 1.41.

Digirad Corp. (NASDAQ:DRAD) last announced its quarterly earnings data on Thursday, July 28th. The company reported $0.09 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.09. Digirad Corp. had a return on equity of 10.03% and a net margin of 34.22%. Equities analysts anticipate that Digirad Corp. will post $0.31 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, August 29th. Shareholders of record on Wednesday, August 17th were paid a $0.05 dividend. The ex-dividend date of this dividend was Monday, August 15th. This represents a $0.20 dividend on an annualized basis and a yield of 4.02%. Digirad Corp.’s dividend payout ratio (DPR) is currently 12.27%.

DRAD has been the topic of a number of research analyst reports. B. Riley restated a “buy” rating and set a $7.00 price target on shares of Digirad Corp. in a report on Sunday, September 11th. Sidoti initiated coverage on Digirad Corp. in a report on Wednesday, May 25th. They set a “buy” rating and a $8.00 price target on the stock. Finally, Zacks Investment Research upgraded Digirad Corp. from a “sell” rating to a “hold” rating in a report on Thursday, September 15th.

A number of institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Digirad Corp. by 437.2% in the second quarter. JPMorgan Chase & Co. now owns 19,340 shares of the company’s stock worth $100,000 after buying an additional 15,740 shares during the period. O Shaughnessy Asset Management LLC boosted its position in shares of Digirad Corp. by 289.4% in the second quarter. O Shaughnessy Asset Management LLC now owns 19,559 shares of the company’s stock worth $101,000 after buying an additional 14,536 shares during the period. AXA bought a new position in shares of Digirad Corp. during the second quarter worth approximately $194,000. Hillsdale Investment Management Inc. boosted its position in shares of Digirad Corp. by 11.9% in the second quarter. Hillsdale Investment Management Inc. now owns 75,280 shares of the company’s stock worth $388,000 after buying an additional 8,000 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of Digirad Corp. by 13.3% in the second quarter. Bank of New York Mellon Corp now owns 81,374 shares of the company’s stock worth $418,000 after buying an additional 9,568 shares during the period. 60.63% of the stock is currently owned by institutional investors and hedge funds.

Digirad Corp. Company Profile

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.

5 Day Chart for NASDAQ:DRAD

Receive News & Ratings for Digirad Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.